[go: up one dir, main page]

HUP9902373A1 - Közeg biológiai anyagok tartósítására - Google Patents

Közeg biológiai anyagok tartósítására

Info

Publication number
HUP9902373A1
HUP9902373A1 HU9902373A HUP9902373A HUP9902373A1 HU P9902373 A1 HUP9902373 A1 HU P9902373A1 HU 9902373 A HU9902373 A HU 9902373A HU P9902373 A HUP9902373 A HU P9902373A HU P9902373 A1 HUP9902373 A1 HU P9902373A1
Authority
HU
Hungary
Prior art keywords
medium
biological materials
preservation
organism
subject
Prior art date
Application number
HU9902373A
Other languages
English (en)
Inventor
André Crespo
Henri-Michel Soria
Original Assignee
Rhone-Poulenc Rorer S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone-Poulenc Rorer S.A. filed Critical Rhone-Poulenc Rorer S.A.
Publication of HUP9902373A1 publication Critical patent/HUP9902373A1/hu
Publication of HUP9902373A3 publication Critical patent/HUP9902373A3/hu
Publication of HU226139B1 publication Critical patent/HU226139B1/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04Preserving or maintaining viable microorganisms

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)

Abstract

A találmány tárgya egy szervezetbe közvetlenül injektálható vagyvisszainjektálható biőlógiai anyagők, példáűl állati sejtek ésvírűsrészecskék tartósítását, és fagyasztőtt tartósítását lehetővétevő közeg. A találmány tárgyát különösen egy őlyan biőlógiai anyagőktartósítására szőlgáló közeg képezi, amely egy sóőldatőt, módősítőttfőlyékőny zselatint és hűmán szérűm albűmint tartalmaz. A közeg mentesminden tőxikűs anyagtól, és közvetlenül beadható egy szervezetbe. Aközeg különböző biőlógiai anyagők, példáűl vírűsők, sejtek,vérlemezkék adőtt esetben fagyasztás főrmájában történő tartósításáraalkalmazható. ŕ
HU9902373A 1996-03-12 1997-03-05 Medium for preserving biological materials HU226139B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9603074A FR2746109B1 (fr) 1996-03-12 1996-03-12 Milieu pour la conservation de materiel biologique
PCT/FR1997/000385 WO1997033975A1 (fr) 1996-03-12 1997-03-05 Milieu pour la conservation de materiel biologique

Publications (3)

Publication Number Publication Date
HUP9902373A1 true HUP9902373A1 (hu) 1999-11-29
HUP9902373A3 HUP9902373A3 (en) 2001-11-28
HU226139B1 HU226139B1 (en) 2008-05-28

Family

ID=9490084

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9902373A HU226139B1 (en) 1996-03-12 1997-03-05 Medium for preserving biological materials

Country Status (14)

Country Link
US (1) US6248588B1 (hu)
EP (1) EP0910622B1 (hu)
JP (1) JP3735123B2 (hu)
KR (1) KR19990087663A (hu)
BR (1) BR9707888A (hu)
CA (1) CA2248200A1 (hu)
CZ (1) CZ297650B6 (hu)
FR (1) FR2746109B1 (hu)
HU (1) HU226139B1 (hu)
IL (1) IL126153A (hu)
NO (1) NO325761B1 (hu)
SK (1) SK287120B6 (hu)
WO (1) WO1997033975A1 (hu)
ZA (1) ZA972101B (hu)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
US7569342B2 (en) 1997-12-10 2009-08-04 Sierra Molecular Corp. Removal of molecular assay interferences
US6248585B1 (en) 1998-11-19 2001-06-19 Thomas Jefferson University Compositions for preserving haptenized tumor cells for use in vaccines
FR2798671A1 (fr) * 1999-09-16 2001-03-23 Univ Paris Curie Compositions de chondrocytes, preparation et utilisations
US20070048726A1 (en) * 2000-01-14 2007-03-01 Biolife Solutions, Inc. Methods and Compositions for the Control of Molecular-Based Cell Death During Preservation of Cells, Tissues or Organs in a Gel-Like State
DE10041515A1 (de) * 2000-08-24 2002-03-14 Gerold Schuler Verfahren zur Herstellung gebrauchsfertiger, Antigen-beladener oder -unbeladener, kryokonservierter reifer dendritischer Zellen
FR2801317A1 (fr) * 2000-11-16 2001-05-25 Univ Paris Curie Methodes et compositions pour la conservation de chondrocytes et utilisations
GB0031065D0 (en) * 2000-12-20 2001-01-31 Univ Cardiff Preservation of cells
CA2447744A1 (en) * 2001-05-21 2002-11-28 Henry Doorly Zoo Method and apparatus for reducing pathogens in a biological sample
US20050133757A1 (en) * 2003-12-22 2005-06-23 Shinya Satoh Cold Storage agent, cold preserving material, and freezer
US20050164908A1 (en) * 2004-01-23 2005-07-28 Ginsberg Myron D. Neuroprotective complex for treatment of cerebral ischemia and injury
CA2623102A1 (en) * 2005-09-22 2007-03-29 Transfert Plus Societe En Commandite Plant extract and use thereof as a cryoprotective agent
ITMI20062287A1 (it) * 2006-11-28 2008-05-29 Anidral Srl Metodo per la preparazi0ne di colture batteriche congelate per utilizzo in campo alimentare dietetico nutraceutico e farmaceutico
GB2499480A (en) 2010-03-31 2013-08-21 Stabilitech Ltd Method for preserving alum adjuvants and alum-adjuvanted vaccines
GB2490644A (en) 2010-03-31 2012-11-07 Stabilitech Ltd Excipients for stabilising viral particles, polypeptides or biological material
DK2898890T3 (da) 2010-03-31 2019-11-25 Stabilitech Biopharma Ltd Stabilisering af viruspartikler
GB201117233D0 (en) 2011-10-05 2011-11-16 Stabilitech Ltd Stabilisation of polypeptides
US10104881B2 (en) * 2012-09-27 2018-10-23 Cefo Co., Ltd. Composition comprising plant-derived recombinant human serum albumin, lipids, and plant protein hydrolysates as active ingredients for cryopreservation of stem cells or primary cells
JP6206792B2 (ja) * 2013-04-03 2017-10-04 誠一 横尾 培地及び細胞の培養方法
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
ES2761854T3 (es) * 2016-10-04 2020-05-21 Albumedix Ltd Usos de albúmina de suero recombinante obtenida a partir de levadura
US11485953B2 (en) * 2016-10-04 2022-11-01 Transwell Biotech Co., Ltd. Compositions and methods for maintaining cell viability
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions
WO2019059235A1 (ja) * 2017-09-19 2019-03-28 株式会社メガカリオン 精製血小板の製造方法、血小板製剤の製造方法、血液製剤の製造方法、血小板保存液、血小板保存剤および血小板の保存方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA702706B (en) * 1969-04-28 1971-12-29 Knox Gelatine Inc Blood plasma substitute
FR2058918A6 (hu) 1969-08-26 1971-05-28 Candy Spa
JPS60228422A (ja) * 1984-04-26 1985-11-13 Suntory Ltd 安定化された生理活性物質製剤
US5219740A (en) 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
WO1988008450A1 (en) 1987-05-01 1988-11-03 Birdwell Finlayson Gene therapy for metabolite disorders
JP3015383B2 (ja) 1987-09-11 2000-03-06 ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ 形質導入した線維芽およびそれらの使用
IL88326A (en) 1987-11-18 1993-03-15 Gist Brocades Nv Purification of serum albumin
JP2914692B2 (ja) 1987-12-11 1999-07-05 ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ 内皮細胞の遺伝子修飾
WO1989007136A2 (en) 1988-02-05 1989-08-10 Whitehead Institute For Biomedical Research Modified hepatocytes and uses therefor
WO1992012242A1 (en) 1990-12-26 1992-07-23 Whitehead Institute For Biomedical Research Modified hepatocytes and uses therefor
IL89992A0 (en) 1988-04-25 1989-12-15 Phillips Petroleum Co Expression of human serum albumin in methylotrophic yeasts
US5045446A (en) * 1988-08-26 1991-09-03 Cryopharm Corporation Lyophilization of cells
US5082670A (en) 1988-12-15 1992-01-21 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
US5538722A (en) 1989-06-13 1996-07-23 Stanford University Isolation, growth, differentiation and genetic engineering of human muscle cells
WO1992009222A1 (en) 1990-11-26 1992-06-11 Britannia Shelving Limited A shelf support system
JPH07501206A (ja) 1991-08-07 1995-02-09 イェシバ・ユニバーシティ 前駆肝細胞の増殖
WO1993007906A1 (en) 1991-10-25 1993-04-29 San Diego Regional Cancer Center Lymphokine gene therapy of cancer
CA2121370C (en) 1991-11-22 2003-03-18 David H. Sachs Specific tolerance in transplantation
GB9125623D0 (en) 1991-12-02 1992-01-29 Dynal As Cell modification
AU3969993A (en) 1992-04-01 1993-11-08 Cornell Research Foundation Inc. Method and recombinant cells for providing increased resistance of hematopoietic progenitor cells to toxicity of chemotherapeutic agents
WO1993024151A1 (en) 1992-05-29 1993-12-09 The General Hospital Corporation Arterial introduction of myoblasts
JPH08501210A (ja) 1992-07-02 1996-02-13 ザ ソールク インスチチュート フォア バイオロジカル スタディズ 遺伝子産物の持続的放出のための筋芽細胞の利用
AU4664693A (en) 1992-07-06 1994-01-31 Research Foundation Of The State University Of New York, The Method of producing genetically modified astrocytes and uses thereof
EP0669973B9 (en) 1992-10-28 2007-10-10 NeuroSpheres Holdings Ltd. Biological factors and neural stem cells
CA2148835A1 (en) 1992-11-09 1994-05-26 Scott Chappel Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs
US5766948A (en) 1993-01-06 1998-06-16 The Regents Of The University Of California Method for production of neuroblasts
FR2709309B1 (fr) 1993-08-25 1995-11-10 Centre Nat Rech Scient Compositions cellulaires, préparation et utilisations thérapeutiques.

Also Published As

Publication number Publication date
FR2746109A1 (fr) 1997-09-19
EP0910622B1 (fr) 2012-09-26
CZ288398A3 (cs) 1998-12-16
IL126153A0 (en) 1999-05-09
FR2746109B1 (fr) 1998-04-17
BR9707888A (pt) 1999-09-21
SK124198A3 (en) 1999-01-11
JP3735123B2 (ja) 2006-01-18
WO1997033975A1 (fr) 1997-09-18
AU720992B2 (en) 2000-06-22
EP0910622A1 (fr) 1999-04-28
HU226139B1 (en) 2008-05-28
IL126153A (en) 2001-08-08
JP2000506024A (ja) 2000-05-23
SK287120B6 (sk) 2009-12-07
CA2248200A1 (fr) 1997-09-18
US6248588B1 (en) 2001-06-19
KR19990087663A (ko) 1999-12-27
AU2163397A (en) 1997-10-01
HUP9902373A3 (en) 2001-11-28
CZ297650B6 (cs) 2007-02-21
NO325761B1 (no) 2008-07-14
NO984053L (no) 1998-09-03
NO984053D0 (no) 1998-09-03
ZA972101B (en) 1997-09-17

Similar Documents

Publication Publication Date Title
HUP9902373A1 (hu) Közeg biológiai anyagok tartósítására
DE69907247D1 (de) Verfahren und vorrichtung zum konservieren von biologischen materialien
Valeri et al. A multicenter study of in vitro and in vivo values in human RBCs frozen with 40‐percent (wt/vol) glycerol and stored after deglycerolization for 15 days at 4° C in AS‐3: assessment of RBC processing in the ACP 215
DE69328685D1 (de) Verfahren zur inaktivierung von bakterien in blutpräparaten mit hilfe von methoxypsoralen
CA2074162A1 (en) Composition to improve survival of biological materials
AU7489687A (en) Translation of mrna
ATE67930T1 (de) Wirkstofftraeger und diesen enthaltende arzneimittel.
BR9915940A (pt) Métodos e composições para restaurar a estabilidade conformacional de uma proteìna da famìlia p53
HUP0203307A2 (hu) Eljárások és készítmények érzékeny biológiai anyagok tartósítására
DK1187530T3 (da) Forbedret opbevaring og holdbarhed af blodprodukter
ES2070076B1 (es) Metodo para aumentar la estabilidad de las nanocapsulas durante su almacenamiento.
DE3881720D1 (de) Geraet zur lagerung und behandlung operativ gewonnener venenstuecke.
ITRM930364A0 (it) Impiego di l-carnitina e alcanoil l-carnitine nella conservazione del sangue per trasfusioni e soluzioni stabilizzatrici che le contengono.
ATE267518T1 (de) Zusammensetzungen und verfahren zum konservieren von blutplättchen
Morgenstern Coated membranes in blood platelets
NO893142D0 (no) Fremgangsmaate for preservering av oftalmologiske opploesninger og sammensetninger for formaalet.
DE3884680D1 (de) Äusseres Membranprotein F von Pseudomonas aeruginosa.
DK338888A (da) Fremgangsmaade til stabilisering af humane leukocyter, isaer granulocyter
IE34180L (en) Method of preservation
RU94045930A (ru) Белки, днк, вектор, клетка, способы получения и очистки белка, фармацевтическая композиция
DK160816C (da) Benzoyl-urinstof-derivater, fremgangsmaade til fremstilling af disse, fremgangsmaade til bekaempelse af insektangreb samt insekticidt middel indeholdende disse
CA2004043A1 (en) Stabilization of leukocytes
DE69302375D1 (de) Kosmetische zusammensetzung zur erhaltung der frisur enthaltend ein milchprotein und/oder ein milchproteinhydrolysate und ein hydrolysate
WO2004050896A8 (en) A method and therapeutic platelets
RU97119167A (ru) Способ осуществления микробной деконтаминации тромбоцитов крови

Legal Events

Date Code Title Description
FH91 Appointment of a representative

Free format text: FORMER REPRESENTATIVE(S): DR. LANG TIVADARNE, S.B.G. & K. SZABADALMI UEGYVIVOEI IRODA, HU

Representative=s name: DANUBIA SZABADALMI ES JOGI IRODA KFT., HU

FH92 Termination of representative

Representative=s name: DR. LANG TIVADARNE, S.B.G. & K. SZABADALMI UEG, HU

MM4A Lapse of definitive patent protection due to non-payment of fees